China ↔ West
A two-way bridge for medical technology.
We connect medical device development, clinical evidence and go-to-market planning between China and Western markets, drawing on many years of clinical pathway experience in China.
China to the West
What does your product need for its selected Western markets?
We help leading Chinese medical technology companies prepare products, evidence and go-to-market for Western markets: market selection, product and claims adaptation, clinical and regulatory pathways, partners, channels and launch.
- Market selection and sequencing
- Product, claims and evidence adaptation
- Clinical and evidence planning for selected markets
- Partners, channels and launch
The West to China
What does your product need for China?
We help Western medical device companies plan for China: intended use, clinical evidence, registration strategy with specialist partners, product localisation, partner selection and commercial launch.
- Chinese clinical pathway planning
- Product localisation planning
- Partner and channel selection
- Commercial launch in China
Why it matters
Plan for selected markets from the design-input stage.
Planning market-specific requirements together can reveal differences in intended use, evidence and product design before they become costly changes.
We align product requirements, evidence needs and go-to-market plans across the selected markets. AI-assisted landscape analysis supports our specialists’ review; our database and algorithm are considered where they fit the product.
Regulatory decisions rest with each market’s authority; timelines depend on the product, its class and its evidence.
Singapore · China · Australia